Visienco AG

Providing automated organoid handling technologies.

Visienco is a Swiss techbio company on a mission to make organoids clinically reliable at scale.

Organoids, lab-grown mini-organs, are transforming how we understand human biology and test therapies. But their full potential is limited by manual, variable, and low-throughput workflows. At Visienco, we develop AI-powered lab automation and data tools to unlock this next chapter of organoid-based research.

Our first product, the Orgadroid, automates one of the biggest bottlenecks: organoid sorting. It replaces repetitive manual steps with an intelligent system that classifies, selects, and transfers organoids with high precision, improving throughput and reproducibility.

Our long-term goal: to enable personalized, data-driven therapies by making organoids a clinically trusted tool.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

19.06.2025

Life sciences, food and space start-ups sweep the prizes at the de Vigier award (startupticker.ch)

16.05.2025

Ten finalists proceed to W. A de Vigier finale (startupticker.ch)

16.05.2025

Eight Venture Kick alumni among finalists for De Vigier Award 2025 (venturekick.ch)

04.03.2025

15 Startups advance to next stage of the W.A. de Vigier Award (startupticker.ch)

No milestones

No Jobs

Videos

Visienco Presentation

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (50'000) 2024

Website